Özlem Türeci is a Turkish-German physician, immunologist and businessperson.[1] She is the co-founder and chief medical officer of BioNTech, president of the Association for Cancer Immunotherapy (CIMT), chair of the Cluster for Individualized Immune Intervention (Ci3) and lecturer at the University of Mainz.[2][3][4][5] Türeci is considered a pioneer in cancer immunotherapy.[2]